Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda

Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda

Background: The World Health Organization-endorsed phenotypic and genotypic drug-susceptibility testing (gDST/pDST) assays for the detection of rifampicin-resistant (RR) tuberculosis (TB), may miss some clinically relevant rpoB mutants, including borderline mutations and mutations outside the gDST-t...

Full description

Bibliographic Details
Main Authors:	Isabel Cuella-Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, Conor Joseph Meehan, Wim Mulders, Bertin Ushizimpumu, Louise De Weerdt, Jelle Keysers, Willem Bram De Rijk, Tom Decroo, Bouke C De Jong, Leen Rigouts
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	International Journal of Mycobacteriology
Subjects:	borderline mutations rpob rifampicin-resistant-conferring mutations rwanda ser450 leu
Online Access:	http://www.ijmyco.org/article.asp?issn=2212-5531;year=2023;volume=12;issue=3;spage=274;epage=281;aulast=Cuella-Martin

Similar Items

Phenotypic Resistance to Rifampicin of <i>Mycobacterium tuberculosis</i> with the <i>rpoB</i> Leu430Pro Mutation
by: D. V. Belyaev, et al.
Published: (2024-11-01)

Pattern of Mutations in Rifampicin Resistance (rpoB) Gene and Analysis of Rifampicin Indeterminate Result in Tuberculosis Detected by Xpert MTB/RIF Assay in Kalaburagi, India
by: M. Ravish Kumar, et al.
Published: (2024-06-01)

Understanding Rifampicin Resistance in Tuberculosis through a Computational Approach
by: Satish Kumar, et al.
Published: (2014-12-01)

Molecular characterisation of rifampicin-resistant <i>Mycobacterium tuberculosis</i> strains from Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017-03-01)

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis
by: Leen Rigouts, et al.
Published: (2023-07-01)

Consequences of rpoB mutations missed by the GenoType MTBDRplus assay in a programmatic setting in South Africa
by: Nomonde R. Mvelase, et al.
Published: (2023-02-01)

Performance of Xpert® MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
by: Tarsizio Chikaonda, et al.
Published: (2017-03-01)

Commentary: Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates
by: Sandeep Sharma, et al.
Published: (2017-11-01)

Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region
by: Pengjiao Ma, et al.
Published: (2021-01-01)

Determination of potentially novel compensatory mutations in rpoc associated with rifampin resistance and rpob mutations in Mycobacterium tuberculosis Clinical isolates from peru
by: Ana Paula Vargas, et al.
Published: (2020-01-01)

Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study
by: Guo J, et al.
Published: (2021-07-01)

A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis
by: Li-Yin Lai, et al.
Published: (2020-10-01)

Sequence Analysis of Rifampicin Resistance Determining Region (RRDR) of Mycobacterium tuberculosis
by: Mitesh Shrestha, et al.
Published: (2018-01-01)

Molecular Characterization of Rifampicin Associated Mutation in Mycobacterium tuberculosis Isolates
by: Ali Tahir, et al.
Published: (2021-06-01)

Detection of rifampicin resistance in methicillin-resistant Staphylococcus aureus isolates from the medical centers at Ahmadu Bello University
by: Maryloveth Oluchukwu Akpudo, et al.
Published: (2023-01-01)

Global prevalence of resistance to rifampicin in Mycobacterium leprae: A meta-analysis
by: Chen Wang, et al.
Published: (2022-12-01)

The Structural Basis of <i>Mycobacterium tuberculosis</i> RpoB Drug-Resistant Clinical Mutations on Rifampicin Drug Binding
by: Arnold Amusengeri, et al.
Published: (2022-01-01)

Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century
by: Jean Claude S. Ngabonziza, et al.
Published: (2022-05-01)

Phenotype versus genotype discordant rifampicin susceptibility testing in tuberculosis: implications for a diagnostic accuracy
by: Mehmood Qadir, et al.
Published: (2024-01-01)

Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France
by: S Spindola de Miranda, et al.
Published: (2001-02-01)

Frequency of genomic mutations mediating resistance of Mycobacterium tuberculosis isolates to rifampicin in Northern Morocco
by: Hind Karimi, et al.

Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022
by: Phyu Win Ei, et al.
Published: (2025-03-01)

Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniae via binding to the RNA polymerase β subunit
by: Mitsunori Tohda, et al.
Published: (2023-03-01)

Relationship between rifampicin resistance and RpoB substitutions of Rhodococcus equi strains isolated in France
by: Sandrine Petry, et al.
Published: (2020-12-01)

Management of falsepositive rifampicin resistant Xpert MTB/RIF – Authors' reply
by: Jean Claude Semuto Ngabonziza, et al.
Published: (2020-10-01)

Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods
by: Winnie Mwanza, et al.
Published: (2018-12-01)

Rifampicin‐resistant RpoB S522L Vibrio vulnificus exhibits disturbed stress response and hypervirulence traits
by: Laura Cutugno, et al.
Published: (2023-10-01)

Molecular characterization of rifampicin-resistant <it>Staphylococcus aureus</it> isolates in a Chinese teaching hospital from Anhui, China
by: Zhou Wenjing, et al.
Published: (2012-10-01)

THE MOLECULAR GENETIC FEATURES OF RIFAMPICIN RESISTANCE AND THE PREVALENCE OF rpoB GENE MUTATIONS IN THE SARATOV REGION
by: T. Yu. Salina, et al.
Published: (2014-04-01)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
by: Armand Van Deun, et al.
Published: (2021-05-01)

Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola
by: Ariadna Rando-Segura, et al.
Published: (2021-10-01)

Accuracy of the InnowaveDX MTB/RIF test for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre study
by: Yunfeng Deng, et al.
Published: (2023-12-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates
by: Chong Teng, et al.
Published: (2024-06-01)

Genetic Determinants of Rifampicin Resistance of Mycobacterium tuberculosis not Included in the Russian Molecular Genetic Test Systems
by: E. A. Mazurina, et al.
Published: (2023-07-01)

Predicting rifampicin resistance mutations in bacterial RNA polymerase subunit beta based on majority consensus
by: Qing Ning, et al.
Published: (2021-04-01)

Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis
by: Noura M. Al-Mutairi, et al.
Published: (2019-01-01)

Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis
by: Mosayeb Rostamian, et al.
Published: (2023-08-01)

Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China
by: Hameed HMA, et al.
Published: (2022-09-01)

Discordance in genotypic and phenotypic drug susceptibility results: time to reconsider critical concentration of rifampicin
by: Arti Shrivas, et al.
Published: (2025-03-01)